Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Molecular Mechanisms in Malignant Lymphoma- Predict

NCT06526065 is registered in ClinicalTrials.gov with University Medical Center Goettingen as lead sponsor.

NCT NCT06526065
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06526065 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Molecular Mechanisms in Malignant Lymphoma- Predict
Lead sponsor
University Medical Center Goettingen
Phase
Observational
Overall status
Recruiting
Start date
June 20, 2024
Completion date
June 1, 2029
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dlbcl - diffuse large b cell lymphoma